Novonix (NVNXF) Receivables - Other (2021 - 2025)

Novonix has reported Receivables - Other for 5 years, with the latest figure at $758973.0 in Q4 2025.

• For the quarter ending Q4 2025, Receivables - Other rose 65.1% year-over-year to $758973.0; the trailing twelve-month figure through Dec 2025 stood at $758973.0 (up 65.1% YoY), and the FY2025 full-year result was $758973.0, up 65.1% from the prior year.
• Receivables - Other for Q4 2025 stood at $758973.0, up from $459718.0 in the prior quarter.
• The five-year high for Receivables - Other was $758973.0 in Q4 2025, with the low at $385664.7 in Q2 2022.
• Historically, Receivables - Other has averaged $507602.5 across 5 years, with a median of $489791.5 in 2022.
• Annual changes were most pronounced in 2024 — Receivables - Other slipped 13.17% — and 2025, when it jumped 65.1%.
• Novonix's Receivables - Other stood at $391958.1 in 2021, then surged by 32.63% to $519865.0 in 2022, then advanced by 1.84% to $529436.0 in 2023, then fell by 13.17% to $459718.0 in 2024, then jumped by 65.1% to $758973.0 in 2025.
• The last three Receivables - Other figures came in at $758973.0 (Q4 2025), $459718.0 (Q4 2024), and $529436.0 (Q4 2023), per Business Quant data.